Sangamo Therapeutics Inc.

NASDAQ: SGMO · Real-Time Price · USD
0.58
0.04 (7.41%)
At close: Aug 15, 2025, 3:59 PM
0.59
1.21%
After-hours: Aug 15, 2025, 07:49 PM EDT

Sangamo Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.1 -0.37 -2.52 -6.08
PEG Ratio
0.03 -0.02 -1.55 -0.17
PS Ratio
3.56 0.54 4.35 9.79
PB Ratio
9.04 1.14 1.64 2.89
P/FCF Ratio
-3.05 -0.39 -1.99 -4.23
P/OCF Ratio
-3.06 -0.42 -2.17 -4.65
OCF/S Ratio
-1.16 -1.28 -2.01 -2.11
Debt / Equity Ratio
1.34 0.46 0.15 0.13
Quick Ratio
1.13 1.98 2.69 3.81
Current Ratio
1.13 1.98 2.69 3.12
Asset Turnover
0.57 1.07 0.20 0.15
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-4.3 -3.11 -0.65 -0.48
Return on Assets
-0.96 -1.56 -0.34 -0.25
Return on Invested Capital
-1.73 -2.2 -0.44 -0.31
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 0.87 0.89 0.91
Net Profit Margin
-1.69 -1.46 -1.73 -1.61
Pretax Profit Margin
-1.7 -1.49 -1.72 -1.61
Operating Profit Margin
-1.8 -1.55 -1.81 -1.66
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-1.54 -1.37 -1.7 -1.57